Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
NCT05305261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197
Last updated 2022-04-08
Summary
This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.
Conditions
- Antibody
- Vaccine
- Maternal
- Cord
Sponsors & Collaborators
-
Malaysia Automotive Robotics and Innovation of Technology Institute
collaborator UNKNOWN -
National University of Malaysia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-29
- Primary Completion
- 2022-03-18
- Completion
- 2022-03-18
Countries
- Malaysia
Study Locations
More Related Trials
-
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468 ·Status: COMPLETED
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery
NCT05564884 ·Status: UNKNOWN
-
Pregnant Women Vaccinated Against Covid-19.
NCT04957953 ·Status: COMPLETED
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
COVID Booster in Pregnancy and Lactation
NCT05543993 ·Status: COMPLETED
-
Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers
NCT04445415 ·Status: UNKNOWN
-
COVID Infection in Pediatric Surgical Patient
NCT05898529 ·Status: RECRUITING
-
Transplacental Transmission of RSV (TTRSV)
NCT05443607 ·Status: ACTIVE_NOT_RECRUITING
-
Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants
NCT06708559 ·Status: ACTIVE_NOT_RECRUITING
-
ANC COVID-19 Surveillance
NCT07021807 ·Status: COMPLETED
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.
NCT04596098 ·Status: COMPLETED
-
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study Freeze and Transport Immune Cells
NCT00138268 ·Status: COMPLETED
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 ·Status: COMPLETED ·Phase: NA
-
Transplacental Transmission of COVID-19
NCT05124574 ·Status: TERMINATED
-
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
NCT05172167 ·Status: UNKNOWN
-
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044 ·Status: ACTIVE_NOT_RECRUITING
-
Saliva PCR in Pregnant Women with COVID-19
NCT06735300 ·Status: COMPLETED
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers
NCT04525417 ·Status: COMPLETED ·Phase: NA